ABCL

Abcellera Biologics Inc (ABCL)

US
$ 2.421.26%

Price Chart

Key Statistics

Market Cap
$ 1.34B
P/E Ratio
0.00
Revenue (TTM)
$ 23.11M
Volume
2.97M
52W High
$ 4.70
52W Low
$ 1.89
Dividend Yield
0.00%
Beta
0.36

Technicals

50-Day MA
2.9612
200-Day MA
2.7965
52 Week High
4.7
52 Week Low
1.8906

About ABCL

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Employees
596
Headquarters
Vancouver, BC
CEO
Dr. Carl L.G. Hansen Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg